Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of preoperative concurrent chemoradiation therapy with S-1 in patients with T4 oral squamous cell carcinoma.
Nomura T, Murakami R, Toya R, Teshima K, Nakahara A, Hirai T, Hiraki A, Nakayama H, Yoshitake Y, Ota K, Obayashi T, Yamashita Y, Oya N, Shinohara M. Nomura T, et al. Among authors: yoshitake y. Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1347-52. doi: 10.1016/j.ijrobp.2009.03.055. Epub 2009 Jul 21. Int J Radiat Oncol Biol Phys. 2010. PMID: 19628343 Clinical Trial.
Aberrant expression of serum amyloid A in head and neck squamous cell carcinoma.
Shinriki S, Ueda M, Ota K, Nakamura M, Kudo M, Ibusuki M, Kim J, Yoshitake Y, Fukuma D, Jono H, Kuratsu J, Shinohara M, Ando Y. Shinriki S, et al. Among authors: yoshitake y. J Oral Pathol Med. 2010 Jan;39(1):41-7. doi: 10.1111/j.1600-0714.2009.00777.x. Epub 2009 Apr 21. J Oral Pathol Med. 2010. PMID: 19453393
Selective inhibition of nuclear factor-κB by nuclear factor-κB essential modulator-binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma.
Tanaka T, Nakayama H, Yoshitake Y, Irie A, Nagata M, Kawahara K, Takamune Y, Yoshida R, Nakagawa Y, Ogi H, Shinriki S, Ota K, Hiraki A, Ikebe T, Nishimura Y, Shinohara M. Tanaka T, et al. Among authors: yoshitake y. Cancer Sci. 2012 Mar;103(3):455-63. doi: 10.1111/j.1349-7006.2011.02174.x. Epub 2012 Jan 16. Cancer Sci. 2012. PMID: 22136381 Free PMC article.
A low Dicer expression is associated with resistance to 5-FU-based chemoradiotherapy and a shorter overall survival in patients with oral squamous cell carcinoma.
Kawahara K, Nakayama H, Nagata M, Yoshida R, Hirosue A, Tanaka T, Nakagawa Y, Matsuoka Y, Kojima T, Takamune Y, Yoshitake Y, Hiraki A, Shinohara M. Kawahara K, et al. Among authors: yoshitake y. J Oral Pathol Med. 2014 May;43(5):350-6. doi: 10.1111/jop.12140. Epub 2013 Dec 10. J Oral Pathol Med. 2014. PMID: 24325353
Sentinel lymph node biopsy reduces the incidence of secondary neck metastasis in patients with oral squamous cell carcinoma.
Hiraki A, Fukuma D, Nagata M, Shiraishi S, Kawahara K, Matsuoka Y, Nakagawa Y, Yoshida R, Tanaka T, Yoshitake Y, Shinohara M, Yamashita Y, Nakayama H. Hiraki A, et al. Among authors: yoshitake y. Mol Clin Oncol. 2016 Jul;5(1):57-60. doi: 10.3892/mco.2016.882. Epub 2016 Apr 28. Mol Clin Oncol. 2016. PMID: 27330766 Free PMC article.
Phase II clinical trial of multiple peptide vaccination for advanced head and neck cancer patients revealed induction of immune responses and improved OS.
Yoshitake Y, Fukuma D, Yuno A, Hirayama M, Nakayama H, Tanaka T, Nagata M, Takamune Y, Kawahara K, Nakagawa Y, Yoshida R, Hirosue A, Ogi H, Hiraki A, Jono H, Hamada A, Yoshida K, Nishimura Y, Nakamura Y, Shinohara M. Yoshitake Y, et al. Clin Cancer Res. 2015 Jan 15;21(2):312-21. doi: 10.1158/1078-0432.CCR-14-0202. Epub 2014 Nov 12. Clin Cancer Res. 2015. PMID: 25391695 Clinical Trial.
238 results